M-End WC Interactions
There are 675 drugs known to interact with M-End WC (brompheniramine / codeine / pseudoephedrine), along with 26 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 134 are major, 534 are moderate, and 7 are minor.
- View all 675 medications that may interact with M-End WC
- View M-End WC alcohol/food interactions (1)
- View M-End WC disease interactions (26)
Most frequently checked interactions
View interaction reports for M-End WC (brompheniramine / codeine / pseudoephedrine) and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- acetaminophen / hydrocodone
- amitriptyline
- Arimidex (anastrozole)
- butalbital
- cyclobenzaprine
- Dilantin (phenytoin)
- Dilaudid (hydromorphone)
- doxycycline
- esomeprazole
- fentanyl
- HydrALAZINE Plus (hydralazine / hydrochlorothiazide)
- hydromorphone
- Lexapro (escitalopram)
- Marinol (dronabinol)
- MetroGel-Vaginal (metronidazole topical)
- MiraLAX (polyethylene glycol 3350)
- naproxen
- Norco (acetaminophen / hydrocodone)
- ondansetron
- paroxetine
- promethazine
- propranolol
- Tribenzor (amlodipine / hydrochlorothiazide / olmesartan)
- zolpidem
- Zometa (zoledronic acid)
M-End WC alcohol/food interactions
There is 1 alcohol/food interaction with M-End WC (brompheniramine / codeine / pseudoephedrine).
M-End WC disease interactions
There are 26 disease interactions with M-End WC (brompheniramine / codeine / pseudoephedrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
More about M-End WC (brompheniramine / codeine / pseudoephedrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.